UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
August 5, 2022 4:00 P.M.
Form:
F-3
CIK:
0001836056
Company Name:
Ambrx Biopharma Inc.
File Number:
333-266404